U.S. Human Growth Hormone Market

Frost & Sullivan, August 2008, Pages: 76

This research service analyzes the changing dynamics in the U.S. human growth hormone market for the period 2004-2014. Included are a pipeline analysis, revenue forecast, patient forecast, market share analysis, product analysis and major trends such as drivers, challenges and restraints. The market is segmented by adult and pediatric. Overviews of the diseases and indications treated by human growth hormone are also provided along with current and future market landscape.

-1 U.S. HUMAN GROWTH HORMONE MARKET

--Overview

---Title
---Disclaimer and Certification
---Table of Contents
---Notes on Methodology

--Market Introduction

---Market Introduction
---Human Growth Hormone: Definition
---Human Growth Hormone Market: Market Overview
---Product Analysis
---Competitive Structure

--Disease Overview and Drug Delivery Systems

---Disease Overview and Drug Delivery Systems
---FDA Approved Indications
---Disease Overview
---Therapy Guidelines
---Pediatric Human Growth Hormone Market
---Adult Human Growth Hormone Market
---Drug Delivery Systems

--New Indications and Challenges

---Idiopathic Short Stature
---Small for Gestational Age

--Hot Topics

---Hot Topics
---The Debate on Bio-generics
---Product Off-label and Investigational Uses
---Debate on Off-label Use of Growth Hormone

--Market Trends

---Market Trends
---Industry Challenges
---Market Drivers
---Market Restraints

--Revenue Analysis

---Revenue Analysis
---Market Engineering Measurements
---Patient Forecast
---Therapy Cost and Treatment Patterns
---Annual Treatment Costs Forecast
---Revenue Forecasts

--Market Share Analysis

---Market Share Analysis
---Company Market Share
---Market Share Discussion

--Clinical Developments and Pipeline

---Clinical Developments and Pipeline
---Clinical Developments
---Ongoing Clinical Trials for Marketed Products

--Company Profiles

---Company Profiles
---Genentech
---Eli Lilly
---Pfizer
---Novo Nordisk
---EMD Serono
---Teva Pharmaceuticals
---Sandoz

--Conclusion

---Conclusion
---Future Competitive Landscape

--About Frost & Sullivan

---Frost & Sullivan

Genentech
Eli Lilly
Pfizer
Novo Nordisk
EMD Serono
Teva Pharmaceuticals
Sandoz

Customers who bought this item also bought

• Growth Hormone Deficiency Global Clinical Trials Review, H1, 2012
• Growth Hormone Deficiency Global Clinical Trials Review, H2 2011
• Growth Hormone Deficiency Global Clinical Trials Review, Q2, 2011
• Global Human Growth Hormone Drugs Market 2011-2015
• Competitor Analysis: Human Growth Hormone (hGH)
• Transdermal Hormone Replacement. Products, Players, Markets, Forecasts
• Global Human Growth Hormone Market Report: 2012 Edition
• Global Biosimilars Market - Products, Applications and Regulations
• The Future of the Biologicals Market: Market overview, innovations and company profiles
• Novel Antibodies & Therapeutic Proteins: Technological Challenges & Future Prospects